Predicate |
Object |
contentType |
Journal Article |
endingPage |
OF6 |
issn |
2159-8274 2159-8290 |
issueIdentifier |
8 |
pageRange |
OF6-OF6 |
publicationName |
Cancer Discovery |
startingPage |
OF6 |
bibliographicCitation |
Erdafitinib Efficacious in Bladder Cancer. Cancer Discov. 2018 Aug;8(8):OF6. doi: 10.1158/2159-8290.cd-nb2018-085. PMID: 29950346. |
date |
2018-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/29950346 https://doi.org/10.1158/2159-8290.cd-nb2018-085 |
isPartOf |
https://portal.issn.org/resource/ISSN/2159-8290 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/39259 https://portal.issn.org/resource/ISSN/2159-8274 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Erdafitinib Efficacious in Bladder Cancer |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67462786 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7053 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7173 |